Sign in

GLUC on OTC

Glucose Health, Inc.

American medicinal chemicals and botanical products company1

In its 2017 annual report the company says: “We are a manufacturer of dietary supplements formulated to help maintain healthy blood sugar, triglycerides and cholesterol and digestive health, and our business focus is serving the consumer market segment of persons concerned about pre-diabetes and/or Type-2 diabetes. We acquired this product in October of 2014, and we are in the early stages of manufacturing, marketing and distributing this product.”12 It is headquartered in Bentonville, Arkansas.1 Its shares trade on OTC under the symbol GLUC.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with China Foods Holdings Ltd., NUTRA PHARMA CORP or Adia Med, Inc., or pick any stock.

  • TickerGLUC on OTC1
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersBentonville, Arkansas1
  • Incorporated inDE2
  • Business address609 Sw 8Th Street, Suite 600, Bentonville, Ar 727122
  • Filer categorySmaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2016

6.1%Gross margin3
-27.7%Operating margin3
-131.0%Net margin3
7232.1%Revenue growth, 20163

Where the money goes

Where each dollar of revenue went, fiscal 2016

  • Cost of revenue48¢$294.1K
  • Interest52¢$323.8K

Out of $313.2K in revenue.3 The company lost money this year.

Financial statements

Revenue43$313.2K in 2016+11336% since 2014
0$100.0K$200.0K$300.0K$400.0K2014: $2.7K$2.7K20142015: $4.3K$4.3K2015+56%2016: $313.2K$313.2K2016+7232%
Gross profit43$19.2K in 2016
-$30.0K-$20.0K-$10.0K0$10.0K$20.0K2014: -$20.7K-$20.7K20142015: $397$39720152016: $19.2K$19.2K2016+4728%
Operating income43-$86.6K in 2016−84% since 2014
-$600.0K-$400.0K-$200.0K02014: -$545.2K-$545.2K20142015: -$156.2K-$156.2K2015−71%2016: -$86.6K-$86.6K2016−45%
Net income43-$410.4K in 2016−39% since 2014
-$800.0K-$600.0K-$400.0K-$200.0K02014: -$669.4K-$669.4K20142015: -$266.1K-$266.1K2015−60%2016: -$410.4K-$410.4K2016+54%
Fiscal year201420152016
Revenue$2.7K4$4.3K3$313.2K3
Cost of revenue$2.6K4$3.9K3$294.1K3
Gross profit-$20.7K4$3973$19.2K3
Research and development$4.0K4$483
Operating income-$545.2K4-$156.2K3-$86.6K3
Interest$109.6K4$120.0K3$323.8K3
Net income-$669.4K4-$266.1K3-$410.4K3
Earnings per share-$0.994-$0.143-$0.153

Compare Glucose Health, Inc. with another company

What it owns

What Glucose Health, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$20.5K3 Dec 31, 2016$2.1K3 Dec 31, 2015+899.6%

Intangibles and goodwill

ItemLatestA year beforeChange
Indefinite-lived intangibles (excluding goodwill)$2403 Dec 31, 2016$3003 Dec 31, 2015−20.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$8.4K3 Dec 31, 2015$04 Dec 31, 2014

Leadership

Who has led Glucose Health, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Murray Fleming2015

Chief financial officer

  1. Murray Fleming2015
20202025

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorJohn Duffy named Sep 10, 20266
  • Executive Officermarc Hatch named Dec 5, 2025 to Sep 10, 20266
  • DirectorChristopher Jemapete named Sep 10, 20266
  • DirectorEdmund Burke named Dec 5, 2025 to Sep 10, 20266
  • DirectorMark Schaftlein named Dec 5, 2025 to Sep 10, 20266
  • DirectorChris Jemapete named Dec 5, 2025 to Jul 7, 20267
  • DirectorEdmunc burke named Feb 4, 20268
  • DirectorFleming Fleming named Dec 5, 20259

Former names

  • Bio-Solutions Corp.Dec 7, 2007 to Dec 16, 20142

Timeline

  1. May 8, 2015New chief executive Murray Fleming becomes CEO5

Filings

14 filings to the SEC since October 2021: 9 private raises, 5 other. The latest 14:

  1. Oct 7, 2026D EDGAR
  2. Oct 6, 2026D EDGAR
  3. Oct 6, 2026D EDGAR
  4. Sep 10, 2026D EDGAR
  5. Jul 7, 2026D EDGAR
  6. Feb 4, 2026D EDGAR
  7. Dec 5, 2025D EDGAR
  8. Jan 19, 2024D/A EDGAR
  9. Dec 7, 2023D EDGAR
  10. Jun 28, 2023RW EDGAR
  11. Jan 9, 2023S-1/A EDGAR
  12. Sep 6, 2022S-1/A EDGAR
  13. Aug 5, 2022S-1/A EDGAR
  14. Jun 1, 2022S-1 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$480.0K 2023–2026
Money received by yearMoney received by year, 2023–2026: $480.0K in all. Private raises (Form D) $480.0K.$0$100K$200K$300K2023 · Private raises (Form D): $290.0K202320242025 · Private raises (Form D): $20.0K20252026 · Private raises (Form D): $170.0K2026
Figures by year
YearPrivate raises (Form D)Total
2026$170.0K$170.0K
2025$20.0K$20.0K
2023$290.0K$290.0K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Aug 28, 2026Raised $10,000 in a private offering of equity6 Form D: $30,000 offered in all Form D
  2. Jun 25, 2026Raised $60,000 in a private offering of equity7 Form D: $120,000 offered in all Form D
  3. Jan 27, 2026Raised $100,000 in a private offering of equity8 Form D: 1 investor so far Form D
  4. Nov 24, 2025Raised $20,000 in a private offering of equity9 Form D: 2 investors so far Form D
  5. Dec 4, 2023Raised $290,000 in a private offering of equity10 Form D: 5 investors so far Form D

SEC filer profile

How Glucose Health, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGlucose Health, Inc.1
  • CIK0001420108
  • Employer ID (EIN)90-11177421
  • Filer statusSmaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address609 Sw 8Th Street, Suite 600, Bentonville, AR 727121
  • Phone479-802-38271
  • Shares outstanding4,545,310 as of Nov 14, 201711
  • Public float$78.5K as of Jun 30, 20163
  • On EDGAR sinceDec 7, 20071
  • Filings139 in all: 10-Q (31), 8-K (25), D (12), NT 10-Q (11), 10-K (9), CORRESP (8), UPLOAD (8), NT 10-K (7)1
    All 23 form types

    10-K/A (5), S-1/A (4), 10-Q/A (3), 424B3 (2), EFFECT (2), S-1 (2), S-8 (2), 10KSB (1), 15-12G (1), 3 (1), 8-A12G (1), 8-K/A (1), D/A (1), RW (1), SB-2 (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2017
    Quarterly report (10-Q) Nov 14, 2017
    Latest 8-K (8-K) Apr 11, 2017

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12